GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Jingfeng Pharmaceutical Co Ltd (SZSE:000908) » Definitions » Capex-to-Operating-Cash-Flow

Hunan Jingfeng Pharmaceutical Co (SZSE:000908) Capex-to-Operating-Cash-Flow : 0.07 (As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Hunan Jingfeng Pharmaceutical Co Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Hunan Jingfeng Pharmaceutical Co's Capital Expenditure for the three months ended in Mar. 2024 was ¥-0.59 Mil. Its Cash Flow from Operations for the three months ended in Mar. 2024 was ¥8.64 Mil.

Hence, Hunan Jingfeng Pharmaceutical Co's Capex-to-Operating-Cash-Flow for the three months ended in Mar. 2024 was 0.07.


Hunan Jingfeng Pharmaceutical Co Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Hunan Jingfeng Pharmaceutical Co's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Jingfeng Pharmaceutical Co Capex-to-Operating-Cash-Flow Chart

Hunan Jingfeng Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.14 - 0.31 0.11 0.30

Hunan Jingfeng Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.31 0.04 - 0.07

Competitive Comparison of Hunan Jingfeng Pharmaceutical Co's Capex-to-Operating-Cash-Flow

For the Drug Manufacturers - General subindustry, Hunan Jingfeng Pharmaceutical Co's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hunan Jingfeng Pharmaceutical Co's Capex-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hunan Jingfeng Pharmaceutical Co's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Hunan Jingfeng Pharmaceutical Co's Capex-to-Operating-Cash-Flow falls into.



Hunan Jingfeng Pharmaceutical Co Capex-to-Operating-Cash-Flow Calculation

Hunan Jingfeng Pharmaceutical Co's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-10.42) / 35.064
=0.30

Hunan Jingfeng Pharmaceutical Co's Capex-to-Operating-Cash-Flow for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-0.588) / 8.644
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hunan Jingfeng Pharmaceutical Co  (SZSE:000908) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Hunan Jingfeng Pharmaceutical Co Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Hunan Jingfeng Pharmaceutical Co's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Hunan Jingfeng Pharmaceutical Co (SZSE:000908) Business Description

Traded in Other Exchanges
N/A
Address
500 Zhangyang Road, Pudong New District, 30th Floor, China Resources Times Square, Shanghai, CHN
Hunan Jingfeng Pharmaceutical Co Ltd is engaged in the manufacturing of pharmaceutical products in China. The company offers Chemical medicine, Biological medicine, and Traditional Chinese medicine. Some of its products include Lemai Wan, Analgesic, Fuping Capsules, and Tongdi Capsules among others.
Executives
Zhou Shen Dong Supervisors
Ye Xiang Wu Directors, executives
Ma Xian Peng Executives
Cong Shu Fen Executives
Zhang Jun Guo Executives
Jian Wei Guang Directors, executives
Bi Yuan Secretary, Director
Ou Yang Yan Li Secretary, Director
Luo Li Director
Luo Bin Director
Li Tong Directors, executives
Wei Ze Chun Director
Tang Zhi Executives
Ou Yang Chun Bao Executives
Mao Hui Executives

Hunan Jingfeng Pharmaceutical Co (SZSE:000908) Headlines

No Headlines